Penn Precision Medicine – Accelerator Fund Projects: Artificial-Intelligence-Driven Targeted Therapy in Acute Myeloid Leukemia

Penn Precision Medicine – Accelerator Fund Projects: Artificial-Intelligence-Driven Targeted Therapy in Acute Myeloid Leukemia

Robert Babak Faryabi, PhD, describes the use of artificial intelligence at the Penn Center for Precision Medicine to develop algorithms to detect and interpret the effects of complex mutations in the cancer genome for patients with acute myeloid leukemia. This information is used to determine which patients will most benefit from specific targeted immunotherapies for the disease. Dr. Faryabi is an Assistant Professor of Pathology and Laboratory Medicine at Penn Medicine.

Related Links:
Enrolling Clinical Trials: Umbilical Cord Blood Transplantation vs Haploidentical Transplantation for Patients with Hematological MalignanciesDr Faryabi’sProfile


Published

February 13, 2018

Created by

Penn Physician VideoLink